A Novel Percutaneous Volume Reduction Technique for Giant Emphysematous Bullae: Combined Percutaneous Erythromycin Sclerotherapy With Bronchoscopic Occlusion
The novel percutaneous bulla volume reduction technique represents a safe and effective non-surgical alternative for patients with inoperable GEB, demonstrating sustained therapeutic benefits lasting at least six months. The procedure appears particularly beneficial for patients with mediastinal displacement. However, the study has limitations, including its retrospective design and lack of long-term efficacy data, which may affect the generalizability of the findings.
Authors
- Hongying Deng
- Jiangchuan Chen (ORCID: https://orcid.org/0000-0002-9216-2351)
- Zeqiang Wang (ORCID: https://orcid.org/0000-0001-8820-4638)
- Xiuying Li (ORCID: https://orcid.org/0000-0002-2322-4790)
- Lingjia Chen
- Huaiqiu Wu
- Yun Li (ORCID: https://orcid.org/0000-0002-5849-5910)
- Wei Liu (ORCID: https://orcid.org/0000-0002-7908-8476)
- Jianlong Tan (ORCID: https://orcid.org/0009-0001-4558-560X)
- Zhiguang Liu (ORCID: https://orcid.org/0000-0002-6196-4810)
- Weidong Zhang (ORCID: https://orcid.org/0009-0008-0588-3996)
Institutions
- Hunan Normal University (CN)
- Hunan Provincial People's Hospital (CN)
Publication Details
- Journal
- International Journal of COPD
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/copd.s495903
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52